BPC-157 / TB-500 Blend 10 mg research-grade lyophilized peptide powder in a glass vial
Hydroxocobalamin 20 mg/ml Injection Solution may also interact with certain foods, such as dairy products, alcohol, and caffeine
Healthcare System Navigation Canadian healthcare providers generally cannot prescribe or officially recommend BPC-157 given its unapproved status
For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety
Hospital Pharmacy (PubMed) Jordan MA, et al